Contents

Current Cancer Therapy Reviews, Volume 4 - Number 2

Dedication to Professor Tony Dodi

, 4(2): i


DOI: 10.2174/157339408784310106




Editorial [Hot Topic: Cancer Biomarkers Guest Editor: Robert C. Rees]

, 4(2): 77 - 78

Robert C. Rees


DOI: 10.2174/157339408784310124




Emerging Breast Cancer Biomarkers

, 4(2): 79 - 85

Stephanie A. Laversin, Amanda K. Miles, Graham R. Ball and Robert C. Rees


DOI: 10.2174/157339408784310179




Overview of Prostate Biomarkers as Potential Targets for Immunotherapy

, 4(2): 86 - 95

Amanda K. Miles, Alistair Roger, Richard Parkinson, Robert C. Rees and Stephanie E.B. McArdle


DOI: 10.2174/157339408784310034




Prognostic Biomarkers of Cutaneous Malignancies – Serological, Immunohistochemical and Proteomic Approaches

, 4(2): 96 - 104

Dirk Schadendorf, Jochen Utikal, Balwir Matharoo-Ball, Robert C. Rees and Selma Ugurel


DOI: 10.2174/157339408784310061




HLA Class I Expression, Tumor Escape and Cancer Progression

, 4(2): 105 - 110

Natalia Aptsiauri, Teresa Cabrera, Angel Garcia Lora, Francisco Ruiz-Cabello and Federico Garrido


DOI: 10.2174/157339408784310052




Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders

, 4(2): 111 - 119

Evelyna Derhovanessian, Cecile Gouttefangeas, Sven Koch and Graham Pawelec


DOI: 10.2174/157339408784310151




NK Cell, Monocyte and Non T Cell Biomarkers as Prognostic Indicators in Cancer Immunotherapy

, 4(2): 120 - 124

Renu Datta, Catherine L. Riley, Italo A. Dodi and Robert C. Rees


DOI: 10.2174/157339408784310133




Lymphocyte Biomarkers of Clinical Responses to Adoptive Immunotherapy of Malignant Melanoma

, 4(2): 125 - 129

Nathalie Labarriere, Brigitte Dreno and Francine Jotereau


DOI: 10.2174/157339408784310142




NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies

, 4(2): 130 - 136

Anastassia Mihaylova, Snejina Mihailova and Elissaveta Naumova


DOI: 10.2174/157339408784310070




Application of Proteomics to the Discovery of Cancer Biomarkers

, 4(2): 137 - 143

Murrium Ahmad and Balwir Matharoo-Ball


DOI: 10.2174/157339408784310089




Protein Glycosylation as Marker of Melanoma Progression

, 4(2): 144 - 148

Anna Litynska, Malgorzata Przybylo, Dorota Hoja-Lukowicz, Ewa Pochec, Marcelina Kremser, Dorota Ciolczyk-Wierzbicka, Maria Labedz and Piotr Laidler


DOI: 10.2174/157339408784310115




Autoantibody Profiles as Biomarkers for Response to Therapy and Early Detection of Cancer

, 4(2): 149 - 156

Zane Kalnina, Karina Silina and Aija Line


DOI: 10.2174/157339408784310160




Computational & Statistical Methodologies to Identify Biomarkers in Cancer

, 4(2): 157 - 160

Graham R. Ball


DOI: 10.2174/157339408784310043




Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines

, 4(2): 161 - 165

Angus G. Dalgleish


DOI: 10.2174/157339408784310098




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science